Nanosonics Limited

Equities

NAN

AU000000NAN9

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 02:10:55 2024-04-23 am EDT 5-day change 1st Jan Change
2.81 AUD 0.00% Intraday chart for Nanosonics Limited -2.09% -36.14%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Nanosonics Chief Technology Officer to Retire MT
Nanosonics Shares Fall 8% as H1 FY24 Revenue Falls 2% to AU$79.6 Million; EPS Slips to AU$0.0202 MT
Transcript : Nanosonics Limited, H1 2024 Earnings Call, Feb 26, 2024
Nanosonics Reports H1 FY24 Revenue Down 2% to AU$79.6 Million; EPS of AU$0.0202 MT
Nanosonics Reports H1 FY24 Revenue Down 2% to AU$79.6 Million; Diluted EPS of AU$0.0202 MT
Nanosonics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Nanosonics Limited Provides Earnings Guidance for the First Half, Second Half and Full Year of 2024 CI
Transcript : Nanosonics Limited - Shareholder/Analyst Call
Nanosonics Limited Announces Appointment of Jason Burriss as Chief Financial Officer, Effective 3 October 2023 CI
Nanosonics Limited Appoints Larry Marshall as Non- Executive Director, Effective from 3 October 2023 CI
Nanosonics Grows Fiscal 2023 Profit, Revenue; Shares Down 3% MT
Nanosonics Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Nanosonics Limited Announces the Appointment of Tracey Batten as Non-Executive Director, Effective 26 September 2023 CI
Nanosonics CFO Resigns MT
Nanosonics Announces Company Secretary Changes CI
Nanosonics Announces the Resignation of McGregor Grant as Chief Financial Officer CI
Nanosonics Fiscal H1 Profit, Revenue Rise MT
Nanosonics to Seek M&A CI
Transcript : Nanosonics Limited, H1 2023 Earnings Call, Feb 23, 2023
Nanosonics Limited Reports Earnings Results for the Half Year Ended December 31, 2022 CI
Heramed Appoints President for North American Unit MT
Energy stocks push Australian shares lower; BHP Group rises RE
Transcript : Nanosonics Limited - Shareholder/Analyst Call
Transcript : Nanosonics Limited, 2022 Earnings Call, Aug 23, 2022
Nanosonics Limited Provides Revenue Guidance for the Fiscal Year 2022 CI
Chart Nanosonics Limited
More charts
Nanosonics Limited is an Australia-based infection prevention company. The Company's principal activities include the manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories. It is focused on the research, development, and commercialization of infection control and decontamination products and related technologies. Trophon technology includes high-frequency ultrasonic vibrations that generate a sonically activated hydrogen peroxide (H2O2) mist that kills bacteria, fungi, and viruses. Its products include trophon2, Nanosonics Auditpro, and trophon electron paramagnetic resonance (EPR). The Company’s trophon2 includes AcuTrace radio frequency identification (RFID) technology, which enables digital record keeping and captures disinfection data. Nanosonics Auditpro provides real-time intelligence on ultrasound probes, operators, and infection control events to manage infection prevention practices across organizations.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
2.81 AUD
Average target price
3.204 AUD
Spread / Average Target
+14.03%
Consensus
  1. Stock Market
  2. Equities
  3. NAN Stock
  4. News Nanosonics Limited
  5. Nanosonics' : Net Profit Declines 74% in July-December 2020; Shares Tumble 7%